Corebridge Financial Inc. Sells 2,826 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Corebridge Financial Inc. reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 5.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,128 shares of the medical device company’s stock after selling 2,826 shares during the quarter. Corebridge Financial Inc.’s holdings in Cooper Companies were worth $4,332,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. LPL Financial LLC boosted its holdings in Cooper Companies by 12.5% in the fourth quarter. LPL Financial LLC now owns 141,604 shares of the medical device company’s stock worth $13,018,000 after acquiring an additional 15,746 shares in the last quarter. Simplify Asset Management Inc. boosted its stake in Cooper Companies by 78.1% in the 4th quarter. Simplify Asset Management Inc. now owns 15,793 shares of the medical device company’s stock worth $1,452,000 after purchasing an additional 6,925 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in Cooper Companies during the 4th quarter valued at about $6,086,000. Sei Investments Co. increased its stake in Cooper Companies by 2.7% during the 4th quarter. Sei Investments Co. now owns 293,265 shares of the medical device company’s stock valued at $26,961,000 after purchasing an additional 7,798 shares in the last quarter. Finally, American Century Companies Inc. raised its holdings in Cooper Companies by 0.9% in the fourth quarter. American Century Companies Inc. now owns 45,210 shares of the medical device company’s stock worth $4,156,000 after buying an additional 412 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on COO shares. Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Morgan Stanley reduced their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Friday, March 7th. Robert W. Baird reduced their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. Finally, Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Trading Down 1.4 %

Cooper Companies stock opened at $83.77 on Monday. The business has a 50-day simple moving average of $89.33 and a two-hundred day simple moving average of $97.21. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market cap of $16.75 billion, a P/E ratio of 42.96, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.